A cost-effectiveness analysis of lusutrombopag for thrombocytopenia in patients with chronic liver disease in Japan.
Norikane MikiSachie InoueHidetoshi ShibaharaKenji KurazonoRodolphe PerardRyosuke TateishiPublished in: JGH open : an open access journal of gastroenterology and hepatology (2021)
LUSU was evaluated as an efficacious and cost-saving treatment option for Japanese CLD patients with thrombocytopenia who required a planned invasive procedure compared with PT and economically should be considered as an alternative treatment.
Keyphrases